Aammaad Shams - 01 Mar 2026 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Accounting Officer
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol: EVH
Transactions as of: 01 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 17:48:31 UTC
Previous filing: 05 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Shams Aammaad	Chief Accounting Officer	C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON	/s/ Jonathan Weinberg, Attorney-in-fact	04 Mar 2026	0001815354

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Tax liability		-2,577	-3.5%	$3.25^*	70,322	01 Mar 2026	Direct	F1, F2
transaction	EVH	Class A Common Stock	Award		+1,686	+2.4%	$0.000000^*	72,008	02 Mar 2026	Direct	F2, F3
transaction	EVH	Class A Common Stock	Tax liability		-850	-1.2%	$3.58^*	71,158	02 Mar 2026	Direct	F2, F4
transaction	EVH	Class A Common Stock	Tax liability		-4,311	-6.1%	$3.51^*	66,847	03 Mar 2026	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Performance-Based Share Unit	Award		+55,173		$0.000000^*	55,173	02 Mar 2026	Class A Common Stock	55,173		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
F2	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3	Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025.
F4	This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.
F5	Represents performance-based share units (PSUs) granted to Mr. Shams pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level.